Focal Segmental Glomerulosclerosis
Open accessThe DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Abstract
Focal segmental glomerulosclerosis (FSGS) is a leading cause of kidney disease worldwide. The presumed etiology of primary FSGS is a plasma factor with responsiveness to immunosuppressive therapy and a risk of recurrence after kidney transplant–important disease characteristics. In contrast, adaptive FSGS is associated with excessive nephron workload due to increased body size, reduced nephron capacity, or single glomerular hyperfiltration associated with certain diseases. Additional etiologies are now recognized as drivers of FSGS: high-penetrance genetic FSGS due to mutations in one of nearly 40 genes, virus-associated FSGS, and medication-associated FSGS. Emerging data support the identification of a sixth category: APOL1 risk allele–associated FSGS in individuals with sub-Saharan ancestry. The classification of a particular patient with FSGS relies on integration of findings from clinical history, laboratory testing, kidney biopsy, and in some patients, genetic testing. The kidney biopsy can be helpful, with clues provided by features on light microscopy ( e.g ., glomerular size, histologic variant of FSGS, microcystic tubular changes, and tubular hypertrophy), immunofluorescence ( e.g ., to rule out other primary glomerulopathies), and electron microscopy ( e.g. , extent of podocyte foot process effacement, podocyte microvillous transformation, and tubuloreticular inclusions). A complete assessment of renal histology is important for establishing the parenchymal setting of segmental glomerulosclerosis, distinguishing FSGS associated with one of many other glomerular diseases from the clinical-pathologic syndrome of FSGS. Genetic testing is beneficial in particular clinical settings. Identifying the etiology of FSGS guides selection of therapy and provides prognostic insight. Much progress has been made in our understanding of FSGS, but important outstanding issues remain, including the identity of the plasma factor believed to be responsible for primary FSGS, the value of routine implementation of genetic testing, and the identification of more effective and less toxic therapeutic interventions for FSGS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Focal segmental glomerulosclerosis (FSGS) is a fibrotic kidney disease characterized by glomerular lesions, particularly in podocytes — the formation of adhesions in the glomerular capillary tuft leads to capillary occlusion and nephron degeneration162.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [162]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,541
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., et al. (2010) · Science · doi:10.1126/science.1193032 · Cited by 2,028 · cited 1×
“More recently, efforts to identify genetic drivers of FSGS in at-risk populations have gained momentum, with the most recent addition including the APOL1 genetic variant as a major association with FSGS in individuals of sub-Saharan African descent with FSGS (23).”
BackgroundSelf-citationMann, J. F., Schmieder, R. E., McQueen, M., Dyal, L., Schumacher, H., Pogue, J., Wang, X., Maggioni, A., Budaj, A., Chaithiraphan, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61236-2 · Cited by 1,589
Combined angiotensin inhibition for the treatment of diabetic nephropathy
Fried, L. F., Emanuele, N., Zhang, J. H., Brophy, M., Conner, T. A., Duckworth, W., Leehey, D. J., McCullough, P. A., O'Connor, T., Palevsky, P. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303154 · Cited by 1,169
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.9 · Cited by 966
KDIGO Clinical Practice Guideline for Glomerulonephritis
Eckardt, K., & Kasiske, B. L. (2012) · Cited by 893
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
Kopp, J. B., Nelson, G. W., Sampath, K., Johnson, R. C., Genovese, G., An, P., Friedman, D., Briggs, W., Dart, R., Korbet, S., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011040388 · Cited by 855
Self-citationCirculating urokinase receptor as a cause of focal segmental glomerulosclerosis
Wei, C., El Hindi, S., Li, J., Fornoni, A., Goes, N., Sageshima, J., Maiguel, D., Karumanchi, S. A., Yap, H.-K., Saleem, M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2411 · Cited by 841
Focal Segmental Glomerulosclerosis
D'Agati, V. D., Kaskel, F. J., & Falk, R. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1106556 · Cited by 825
Pathologic classification of focal segmental glomerulosclerosis: a working proposal
D'Agati, V. D., Fogo, A. B., Bruijn, J. A., & Jennette, J. C. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.10.024 · Cited by 776
The spectrum of podocytopathies: A unifying view of glomerular diseases
Wiggins, R.-C. (2007) · Kidney International · doi:10.1038/sj.ki.5002222 · Cited by 757
The incidence of primary glomerulonephritis worldwide: a systematic review of the literature
McGrogan, A., Franssen, C. F. M., & de Vries, C. S. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq665 · Cited by 741
A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome
Sadowski, C. E., Lovric, S., Ashraf, S., Pabst, W. L., Gee, H. Y., Kohl, S., Engelmann, S., Vega-Warner, V., Fang, H., Halbritter, J., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014050489 · Cited by 651
Progression of glomerular diseases: Is the podocyte the culprit?
Kriz, W., Gretz, N., & Lemley, K. V. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00044.x · Cited by 592
Collapsing Focal Segmental Glomerulosclerosis Following Treatment with High-Dose Pamidronate
MARKOWITZ, G. S., APPEL, G. B., FINE, P. L., FENVES, A. Z., LOON, N. R., JAGANNATH, S., KUHN, J. A., DRATCH, A. D., & D'AGATI, V. D. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1261164 · Cited by 466
Adriamycin nephropathy: A model of focal segmental glomerulosclerosis
LEE, V. W., & HARRIS, D. C. (2011) · Nephrology · doi:10.1111/j.1440-1797.2010.01383.x · Cited by 433
Broderick, T. F. (1955) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-195537010-00032 · Cited by 398
Abatacept in B7-1–Positive Proteinuric Kidney Disease
Yu, C.-C., Fornoni, A., Weins, A., Hakroush, S., Maiguel, D., Sageshima, J., Chen, L., Ciancio, G., Faridi, M. H., Behr, D., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304572 · Cited by 384
Causes and pathogenesis of focal segmental glomerulosclerosis
Fogo, A. B. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.216 · Cited by 360
Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1
Nichols, B., Jog, P., Lee, J. H., Blackler, D., Wilmot, M., D'Agati, V., Markowitz, G., Kopp, J. B., Alper, S. L., Pollak, M. R., et al. (2015) · Kidney International · doi:10.1038/ki.2014.270 · Cited by 355
Self-citationCattran, D. C., Appel, G. B., Hebert, L. A., Hunsicker, L. G., Pohl, M. A., Hoy, W. E., Maxwell, D. R., & Kunis, C. L. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00778.x · Cited by 326
APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans
Kasembeli, A. N., Duarte, R., Ramsay, M., Mosiane, P., Dickens, C., Dix-Peek, T., Limou, S., Sezgin, E., Nelson, G. W., Fogo, A. B., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014050469 · Cited by 326
Self-citationTwenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States
Kitiyakara, C., Eggers, P., & Kopp, J. B. (2004) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(04)01081-9 · Cited by 303
Self-citationMarras, D., Bruggeman, L. A., Gao, F., Tanji, N., Mansukhani, M. M., Cara, A., Ross, M. D., Gusella, G. L., Benson, G., D'Agati, V. D., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-522 · Cited by 303
Nephron mass as a risk factor for progression of renal disease.
Brenner, B. M., & Mackenzie, H. S. (1997) · PubMed · Cited by 287
A Potential Role for Mechanical Forces in the Detachment of Podocytes and the Progression of CKD
Kriz, W., & Lemley, K. V. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014030278 · Cited by 286
Trautmann, A., Bodria, M., Ozaltin, F., Gheisari, A., Melk, A., Azocar, M., Anarat, A., Caliskan, S., Emma, F., Gellermann, J., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06260614 · Cited by 283
Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants
Thomas, D. B., Franceschini, N., Hogan, S. L., ten Holder, S., Jennette, C. E., Falk, R. J., & Jennette, J. C. (2006) · Kidney International · doi:10.1038/sj.ki.5000160 · Cited by 281
Trachtman, H., Fervenza, F. C., Gipson, D. S., Heering, P., Jayne, D. R. W., Peters, H., Rota, S., Remuzzi, G., Rump, L. C., Sellin, L. K., et al. (2011) · Kidney International · doi:10.1038/ki.2011.33 · Cited by 263
Gast, C., Pengelly, R. J., Lyon, M., Bunyan, D. J., Seaby, E. G., Graham, N., Venkat-Raman, G., & Ennis, S. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv325 · Cited by 254
A Proposed Taxonomy for the Podocytopathies: A Reassessment of the Primary Nephrotic Diseases
Barisoni, L., Schnaper, H. W., & Kopp, J. B. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04121206 · Cited by 249
Self-citationCorticosteroid therapy for nephrotic syndrome in children
Hahn, D., Hodson, E. M., Willis, N. S., & Craig, J. C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001533.pub5 · Cited by 248
Delville, M., Sigdel, T. K., Wei, C., Li, J., Hsieh, S.-C., Fornoni, A., Burke, G. W., Bruneval, P., Naesens, M., Jackson, A., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008538 · Cited by 232
The incidence of biopsy‐proven glomerulonephritis in Australia
Briganti, E. M., Dowling, J., Finlay, M., Hill, P. A., Jones, C. L., Kincaid‐Smith, P. S., Sinclair, R., McNeil, J. J., & Atkins, R. C. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.7.1364 · Cited by 232
Pirfenidone Slows Renal Function Decline in Patients with Focal Segmental Glomerulosclerosis
Cho, M. E., Smith, D. C., Branton, M. H., Penzak, S. R., & Kopp, J. B. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01050207 · Cited by 222
Self-citationObesity and Kidney Disease: Potential Mechanisms
Wickman, C., & Kramer, H. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.12.006 · Cited by 213
Larsen, C. P., Beggs, M. L., Saeed, M., & Walker, P. D. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012121180 · Cited by 207
A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis.
Rich, A. (1957) · PubMed · Cited by 205
High Sirolimus Levels May Induce Focal Segmental Glomerulosclerosis De Novo
Letavernier, E., Bruneval, P., Mandet, C., Van Huyen, J.-P. D., Pe[Combining Acute Accent]raldi, M.-N. D., Helal, I., Noe[Combining Diaeresis]l, L.-H. A. A. G. A., & Legendre, C. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03751106 · Cited by 200
The Importance of Sample Size in the Interpretation of the Renal Biopsy
Corwin, H. L., Schwartz, M. M., & Lewis, E. J. (1988) · American Journal of Nephrology · doi:10.1159/000167563 · Cited by 197
Resolution of Recurrent Focal Segmental Glomerulosclerosis after Retransplantation
Gallon, L., Leventhal, J., Skaro, A., Kanwar, Y., & Alvarado, A. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1202500 · Cited by 197
Development of Focal Segmental Glomerulosclerosis after Anabolic Steroid Abuse
Herlitz, L. C., Markowitz, G. S., Farris, A. B., Schwimmer, J. A., Stokes, M. B., Kunis, C., Colvin, R. B., & D'Agati, V. D. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009040450 · Cited by 192
Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis
Deegens, J. K. J., Dijkman, H. B. P. M., Borm, G. F., Steenbergen, E. J., van den Berg, J. G., Weening, J. J., & Wetzels, J. F. M. (2008) · Kidney International · doi:10.1038/ki.2008.413 · Cited by 179
Treatment of Primary FSGS in Adults
Korbet, S. M. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012040389 · Cited by 170
Growth-Dependent Podocyte Failure Causes Glomerulosclerosis
Fukuda, A., Chowdhury, M. A., Venkatareddy, M. P., Wang, S. Q., Nishizono, R., Suzuki, T., Wickman, L. T., Wiggins, J. E., Muchayi, T., Fingar, D., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012030271 · Cited by 170
MYH9 and APOL1 are both associated with sickle cell disease nephropathy
Ashley‐Koch, A. E., Okocha, E. C., Garrett, M. E., Soldano, K., De Castro, L. M., Jonassaint, J. C., Orringer, E. P., Eckman, J. R., & Telen, M. J. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08832.x · Cited by 160
Direct effects of dexamethasone on human podocytes
Xing, C.-Y., Saleem, M. A., Coward, R. J., Ni, L., Witherden, I. R., & Mathieson, P. W. (2006) · Kidney International · doi:10.1038/sj.ki.5001655 · Cited by 159
Larkins, N., Liu, I. D., Willis, N. S., Craig, J. C., & Hodson, E. M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002290.pub5 · Cited by 156
Corticosteroid therapy for nephrotic syndrome in children
Hahn, D., Samuel, S., Willis, N. S., Craig, J. C., & Hodson, E. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001533.pub2 · Cited by 149
Büscher, A. K., Beck, B. B., Melk, A., Hoefele, J., Kranz, B., Bamborschke, D., Baig, S., Lange-Sperandio, B., Jungraithmayr, T., Weber, L. T., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07370715 · Cited by 148
HIV-1 Nef Induces Proliferation and Anchorage-Independent Growth in Podocytes
Husain, M., Gusella, G. L., Klotman, M. E., Gelman, I. H., Ross, M. D., Schwartz, E. J., Cara, A., & Klotman, P. E. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000019642.55998.69 · Cited by 145
Sim, J. J., Batech, M., Hever, A., Harrison, T. N., Avelar, T., Kanter, M. H., & Jacobsen, S. J. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.03.416 · Cited by 145
Ando, K., Ohtsu, H., Uchida, S., Kaname, S., Arakawa, Y., & Fujita, T. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70194-9 · Cited by 134
Glomerular hyperfiltration and albuminuria in children with sickle cell anemia
Aygun, B., Mortier, N. A., Smeltzer, M. P., Hankins, J. S., & Ware, R. E. (2011) · Pediatric Nephrology · doi:10.1007/s00467-011-1857-2 · Cited by 133
Schmid, H., Henger, A., Cohen, C. D., Frach, K., Gröne, H.-J., Schlöndorff, D., & Kretzler, M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000090745.85482.06 · Cited by 133
Disruption of PTPRO Causes Childhood-Onset Nephrotic Syndrome
Özaltın, F., Ibsirlioglu, T., Taşkıran, E. Z., Baydar, D. E., Kaymaz, F. F., Büyükçelik, M., Kılıç, B. D., Balat, A., Iatropoulos, P., Aşan, E., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.05.026 · Cited by 130
Canaud, G., Zuber, J., Sberro‐Soussan, R., Royale, V., Anglicheau, D., Snanoudj, R., Gaha, K., Thervet, É., Lefrère, F., Cavazzana, M., et al. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02580.x · Cited by 129
Kopp, J. B., Winkler, C. A., Zhao, X., Radeva, M. K., Gassman, J. J., D’Agati, V. D., Nast, C. C., Wei, C., Reiser, J., Guay-Woodford, L. M., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013111242 · Cited by 127
Self-citationA reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease
Spinale, J. M., Mariani, L. H., Kapoor, S. C., Zhang, J., Weyant, R., Song, P. X. ‐., Wong, H. N., Troost, J. P., Gadegbeku, C. A., Gipson, D. S., et al. (2014) · Kidney International · doi:10.1038/ki.2014.346 · Cited by 124
Nayagam, L. S., Ganguli, A. X., Rathi, M., Kohli, H. S., Gupta, K. L., Joshi, K., Sakhuja, V., & Jha, V. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm538 · Cited by 112
Focal segmental glomerulosclerosis: towards a better understanding for the practicing nephrologist
Sethi, S., Glassock, R. J., & Fervenza, F. C. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu035 · Cited by 108
Dijkman, H. B. P. M., Weening, J. J., Smeets, B., Verrijp, K. C. N., Kuppevelt, T. H. V., Assmann, K. K. J. M., Steenbergen, E. J., & Wetzels, J. F. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001574 · Cited by 108
Treatment of Idiopathic FSGS with Adrenocorticotropic Hormone Gel
Hogan, J., Bomback, A. S., Mehta, K. R., Canetta, P. A., Rao, M. K., Appel, G. B., Radhakrishnan, J., & Lafayette, R. A. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02840313 · Cited by 105
IgM Contributes to Glomerular Injury in FSGS
Strassheim, D., Renner, B., Panzer, S. E., Fuquay, R., Kulik, L. N., Ljubanović, D. G., Holers, V. M., & Thurman, J. M. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012020187 · Cited by 105
Shavit, L., Lifschitz, M. D., & Epstein, M. (2012) · Kidney International · doi:10.1038/ki.2011.505 · Cited by 104
Canaud, G., Dion, D., Zuber, J., Gübler, M.-C., Sberro‐Soussan, R., Thervet, É., Snanoudj, R., Charbit, M., Salomon, R., Martinez, F., et al. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp500 · Cited by 104
Immunosuppressive treatment for focal segmental glomerulosclerosis in adults
Braun, N., Schmutzler, F., Lange, C., Perna, A., Remuzzi, G., & Willis, N. S. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003233.pub2 · Cited by 102
Huang, J., Liu, G., Zhang, Y.-M., Cui, Z., Wang, F., Liu, X., Chu, R., Chen, Y., & Zhao, M. (2013) · Kidney International · doi:10.1038/ki.2013.55 · Cited by 96
Pathogenesis and therapy of focal segmental glomerulosclerosis: an update
Gbadegesin, R., Lavin, P., Foreman, J. W., & Winn, M. P. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1692-x · Cited by 96
The podocyte as a direct target for treatment of glomerular disease?
Mallipattu, S. K., & He, C. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00184.2016 · Cited by 96
Hanly, P. J., & Ahmed, S. B. (2014) · CHEST Journal · doi:10.1378/chest.14-0596 · Cited by 92
Komatsu, K., Frohlich, E. D., Ono, H., Ono, Y., Numabe, A., & Willis, G. W. (1995) · Hypertension · doi:10.1161/01.hyp.25.2.207 · Cited by 92
Primary Focal Segmental Glomerulosclerosis: Pathology, Histological Variants, and Pathogenesis
Schwartz, M. M., & Korbet, S. M. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70349-9 · Cited by 90
Renal and Hematological Effects of CLCF-1, a B-Cell-Stimulating Cytokine of the IL-6 Family
Savin, V. J., Sharma, M., Zhou, J., Genochi, D., Fields, T. A., Sharma, R., McCarthy, E. T., Srivastava, T., Domen, J., Tormo, A. J., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/714964 · Cited by 87
Serum suPAR in patients with FSGS: trash or treasure?
Maas, R. J. H., Deegens, J. K., & Wetzels, J. F. M. (2013) · Pediatric Nephrology · doi:10.1007/s00467-013-2452-5 · Cited by 87
Joy, M. S., Gipson, D. S., Powell, L., MacHardy, J., Jennette, J. C., Vento, S., Pan, C. G., Savin, V. J., Eddy, A. A., Fogo, A. B., et al. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.08.019 · Cited by 87
Self-citationPathobiology of focal segmental glomerulosclerosis: new developments
D’Agati, V. D. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32835200df · Cited by 87
Mechanical challenges to the glomerular filtration barrier: adaptations and pathway to sclerosis
Kriz, W., & Lemley, K. V. (2016) · Pediatric Nephrology · doi:10.1007/s00467-016-3358-9 · Cited by 87
Serum-soluble urokinase receptor concentration in primary FSGS
Maas, R. J. H., Wetzels, J. F. M., & Deegens, J. K. (2012) · Kidney International · doi:10.1038/ki.2012.32 · Cited by 84
Chronic Kidney Disease in Congenital Heart Disease Patients: A Narrative Review of Evidence
Morgan, C., Al-Aklabi, M., & Guerra, G. G. (2015) · Canadian Journal of Kidney Health and Disease · doi:10.1186/s40697-015-0063-8 · Cited by 83
Pravitsitthikul, N., Willis, N. S., Hodson, E. M., & Craig, J. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002290.pub4 · Cited by 83
Focal Segmental Glomerulosclerosis and Chronic Kidney Disease in Pediatric Patients
Kiffel, J., Rahimzada, Y., & Trachtman, H. (2011) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2011.03.005 · Cited by 77
A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues
Wada, T., & Nangaku, M. (2015) · Clinical Kidney Journal · doi:10.1093/ckj/sfv090 · Cited by 77
Viruses and collapsing glomerulopathy: a brief critical review: Table 1.
Chandra, P., & Kopp, J. B. (2013) · Clinical Kidney Journal · doi:10.1093/ckj/sft002 · Cited by 76
Self-citationMallipattu, S. K., Guo, Y., Revelo, M. P., Roa‐Peña, L., Miller, T., Ling, J., Shankland, S. J., Bialkowska, A. B., Ly, V., Estrada, C. C., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015060672 · Cited by 76
Trachtman, H., Vento, S., Herreshoff, E. G., Radeva, M., Gassman, J., Stein, D. T., Savin, V. J., Sharma, M., Reiser, J., Wei, C., et al. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0094-5 · Cited by 74
Ikezumi, Y., Suzuki, T., Karasawa, T., Yamada, T., Hasegawa, H., Nishimura, H., & Uchiyama, M. (2013) · American Journal of Nephrology · doi:10.1159/000353898 · Cited by 73
Harris, J. J., McCarthy, H. J., Ni, L., Wherlock, M. D., Kang, H. G., Wetzels, J. F. M., Welsh, G. I., & Saleem, M. A. (2012) · The Journal of Pathology · doi:10.1002/path.4149 · Cited by 73
Morphologic Variants of Focal Segmental Glomerulosclerosis and Their Significance
Stokes, M. B., & D’Agati, V. D. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.02.010 · Cited by 72
Sirolimus Therapy of Focal Segmental Glomerulosclerosis Is Associated With Nephrotoxicity
Cho, M. E., Hurley, J. K., & Kopp, J. B. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.10.020 · Cited by 69
Self-citationFocal segmental glomerulosclerosis: molecular genetics and targeted therapies
Chen, Y. M., & Liapis, H. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0090-9 · Cited by 66
Sgambat, K., Banks, M., & Moudgil, A. (2013) · Pediatric Nephrology · doi:10.1007/s00467-013-2539-z · Cited by 65
López-Hellín, J., Cantarell, C., Jimeno, L., Sánchez-Fructuoso, A. I., Puig-Gay, N., Guirado, L., Vilariño, N., González-Roncero, F. M., Mazuecos, A., Lauzurica, R., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04338.x · Cited by 62
Secondary collapsing glomerulopathy associated with Loa Loa filariasis
Pakasa, N. M., Nseka, N. M., & Nyimi, L. M. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90090-1 · Cited by 61
Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series
Madan, A., Mijovic-Das, S., Stankovic, A. R., Teehan, G. S., Milward, A. S., & Khastgir, A. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0241-7 · Cited by 61
A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis
Yu, H., Artomov, M., Brähler, S., Stander, M. C., Shamsan, G., Sampson, M. G., White, J. M., Kretzler, M., Miner, J. H., Jain, S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82592 · Cited by 59
Self-citationTreatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS
Laurin, L., Gasim, A., Poulton, C. J., Hogan, S. L., Jennette, J. C., Falk, R. J., Foster, B. J., & Nachman, P. H. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07110615 · Cited by 59
Is focal segmental glomerulosclerosis really focal? Distribution of lesions in adults and children
Fogo, A. B., Glick, A. D., Horn, S. R. G.-V., & Horn, R. G. (1995) · Kidney International · doi:10.1038/ki.1995.234 · Cited by 56
Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide
Hari, P., Bagga, A., Jindal, N., & Srivastava, R. N. (2001) · Pediatric Nephrology · doi:10.1007/s004670100680 · Cited by 53
Silverstein, D. M., & Craver, R. D. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00230107 · Cited by 50
Mariani, L. H., Pendergraft, W. F., & Kretzler, M. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.13651215 · Cited by 47
Teeninga, N., Holthe, J. E. K., van den Akker, E. L. T., Kersten, M. C., Boersma, E. H., Krabbe, H. G., Knoers, N. V. A. M., van der Heijden, A. J., Koper, J. W., & Nauta, J. (2014) · Kidney International · doi:10.1038/ki.2013.531 · Cited by 46
Gasser, D. L., Winkler, C. A., Peng, M., An, P., McKenzie, L. M., Kirk, G. D., Shi, Y., Xie, L. X., Marbois, B. N., Clarke, C. F., et al. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00143.2013 · Cited by 45
Self-citationHiramatsu, N., Hiromura, K., Shigehara, T., Kuroiwa, T., Ideura, H., Sakurai, N., Takeuchi, S., Tomioka, M., Ikeuchi, H., Kaneko, Y., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006030217 · Cited by 44
Self-citationDystroglycan in the Diagnosis of FSGS
Giannico, G. A., Yang, H., Neilson, E. G., & Fogo, A. B. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01510209 · Cited by 43
New players in the pathogenesis of focal segmental glomerulosclerosis
Schell, C., & Huber, T. B. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs273 · Cited by 43
Kachurina, N., Chung, C.-F., Benderoff, E., Babayeva, S., Bitzan, M. M., Goodyer, P., Kitzler, T. M., Matar, D., Cybulsky, A. V., Alachkar, N., et al. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00349.2015 · Cited by 43
Sethna, C. B., & Gipson, D. S. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.01.010 · Cited by 42
Beer, A., Mayer, G. J., & Kronbichler, A. (2016) · BioMed Research International · doi:10.1155/2016/4192578 · Cited by 41
Cheng, J.-W., Zhang, X., Tian, J., Li, Q., & Chen, J.-M. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02970.x · Cited by 40
Asinobi, A. O., Ademola, A. D., Okolo, C. A., & Yaria, J. O. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0208-0 · Cited by 39
Role of Myeloid-Derived Suppressor Cells in Glucocorticoid-Mediated Amelioration of FSGS
Li, L., Zhang, T., Diao, W., Jin, F., Shi, L., Meng, J., Liu, H., Zhang, J., Zeng, C.-H., Zhang, M.-C., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014050468 · Cited by 38
Collapsing Glomerulopathy Following Anthracycline Therapy
Mohamed, N., Goldstein, J., Schiff, J. R., & John, R. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.08.048 · Cited by 36
An update on the treatment options for focal segmental glomerulosclerosis
Meyrier, A. Y. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902754029 · Cited by 31
Practical Application of Columbia Classification for Focal Segmental Glomerulosclerosis
Han, M., & Kim, Y. (2016) · BioMed Research International · doi:10.1155/2016/9375753 · Cited by 31
Lithium-induced nephrotic syndrome in a young pediatric patient
Şakarcan, A., Thomas, D. B., O’Reilly, K. P., & Richards, R. W. (2002) · Pediatric Nephrology · doi:10.1007/s00467-001-0809-7 · Cited by 30
Immunologic Changes Implicated in the Pathogenesis of Focal Segmental Glomerulosclerosis
Kronbichler, A., Leierer, J., Oh, J. S., Meijers, B. K. I., & Shin, J. I. (2016) · BioMed Research International · doi:10.1155/2016/2150451 · Cited by 29
Corticosteroid therapy for nephrotic syndrome in children
Hodson, E., Knight, J. F., Willis, N. S., & Craig, J. C. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001533 · Cited by 29
A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis
Yu, H., Artomov, M., Brähler, S., Stander, M. C., Shamsan, G. A., Sampson, M. G., White, J. M., Kretzler, M., Miner, J. H., Jain, S. R., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87342 · Cited by 28
Self-citationLieberman, K. V., & Pavlova-Wolf, A. (2016) · Journal of Nephrology · doi:10.1007/s40620-016-0308-3 · Cited by 27
Saquinavir in steroid-dependent and -resistant nephrotic syndrome: a pilot study
Coppo, R., Camilla, R., Porcellini, M. G., Peruzzi, L., Gianoglio, B., Amore, A., Daprà, V., Loiacono, E., Fonsato, V., Canton, A. D., et al. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs035 · Cited by 26
Peng, Z., Mao, J., Chen, X., Cai, F., Gu, W., Fu, H., Shen, H., Wang, J., Jin, X., Zhu, X., et al. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2892-6 · Cited by 25
Progress in MS—classification, mechanisms and treatment
Oh, J., & O'Connor, P. W. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.259 · Cited by 24
Focal and Segmental Glomerulosclerosis: Multiple Pathways Are Involved
Meyrier, A. Y. (2011) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2011.06.003 · Cited by 24
Martinelli, R. P., Pereira, L. J. C., Brito, E., & Rocha, H. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000188427 · Cited by 23
Current and emerging treatments for idiopathic focal and segmental glomerulosclerosis in adults
Ponticelli, C. E., & Graziani, G. (2013) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.109 · Cited by 23
Fan, L., Liu, Q., Liao, Y., Li, Z., Ji, Y., Yang, Z., Chen, J., Fu, J., Zhang, J., Kong, Y., et al. (2012) · International Urology and Nephrology · doi:10.1007/s11255-012-0205-1 · Cited by 22
The Treatment of Idiopathic Focal Segmental Glomerulosclerosis in Adults
Hogan, J., & Radhakrishnan, J. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.03.016 · Cited by 22
Renin-angiotensin axis blockade reduces proteinuria in presymptomatic patients with familial FSGS
Copelovitch, L. A., Guttenberg, M. E., Pollak, M. R., & Kaplan, B. S. (2007) · Pediatric Nephrology · doi:10.1007/s00467-007-0505-3 · Cited by 22
Corticosteroid therapy for nephrotic syndrome in children
ORSINI, M., & Boscherini, B. (2015) · Nephrology · doi:10.1111/nep.12590 · Cited by 22
Different Targets for Treating Focal Segmental Glomerular Sclerosis
Coppo, R. (2013) · Contributions to nephrology · doi:10.1159/000348637 · Cited by 21
Computational simulation of renal biopsy accuracy in focal segmental glomerulosclerosis
Schachter, A. D. (2006) · Pediatric Nephrology · doi:10.1007/s00467-006-0127-1 · Cited by 21
Hirakawa, M., Tsuruya, K., Yotsueda, H., Tokumoto, M., Ikeda, H., Katafuchi, R., Fujimi, S., Hirakata, H., & Iida, M. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.02.031 · Cited by 20
Meehan, S. M., Chang, A., Gibson, I. W., Kim, L., Kambham, N., & Laszik, Z. G. (2012) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-012-1355-3 · Cited by 20
Wągrowska‐Danilewicz, M., & Danilewicz, M. (2007) · PubMed · Cited by 19
on behalf of Impact of Combined Losartan/Hydrochlorothiazide on Proteinuria in Patients with Chronic Kidney Disease and Hypertension (ILOHA) Study Investigators, Fujisaki, K., Tsuruya, K., Nakano, T., Taniguchi, M., Higashi, H., Katafuchi, R., Kanai, H., Nakayama, M., Hirakata, H., et al. (2014) · Hypertension Research · doi:10.1038/hr.2014.110 · Cited by 19
Meehan, S. M., Kim, L., & Chang, A. (2012) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-012-1213-3 · Cited by 17
Jafry, N. H., Ahmed, E., Mubarak, M., Kazi, J. I., & Akhter, F. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr430 · Cited by 17
Collapsing Focal Segmental Glomerulosclerosis in a Patient with Acute Malaria
Sehar, N., Gobran, E., & El‐Sayegh, S. (2015) · Case Reports in Medicine · doi:10.1155/2015/420459 · Cited by 16
Zhong, Y., Xu, F., Li, X., Chen, H., Liang, S., Zhu, X., Liu, Z., & Zeng, C. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv245 · Cited by 14
Renin–angiotensin–aldosterone system inhibitors in pediatric focal segmental glomerulosclerosis
Kangovi, S., Edwards, M., Woloszynek, S., Mitra, N., Feldman, H. I., Kaplan, B. S., & Meyers, K. E. C. (2011) · Pediatric Nephrology · doi:10.1007/s00467-011-2056-x · Cited by 12
Changing the Paradigm for the Treatment and Development of New Therapies for FSGS
Spino, C., Jahnke, J., Selewski, D. T., Massengill, S. F., Troost, J. P., & Gipson, D. S. (2016) · Frontiers in Pediatrics · doi:10.3389/fped.2016.00025 · Cited by 10
The sclerosing glomerulus in mice and man
Mondini, A., Messa, P., & Rastaldi, M. P. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000444817.95496.40 · Cited by 6
Cited by
Heavy metals: toxicity and human health effects
Jomova, K., Alomar, S. Y., Nepovimova, E., Kuca, K., & Valko, M. (2025) · Archives of Toxicology · doi:10.1007/s00204-024-03903-2 · Cited by 983
Kopp, J. B., Anders, H.-J., Susztak, K., Podestà, M. A., Remuzzi, G., Hildebrandt, F., & Romagnani, P. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0196-7 · Cited by 562
Self-citationAutophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
Cellular and molecular mechanisms of kidney fibrosis
Djudjaj, S., & Boor, P. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.06.002 · Cited by 475
Chung, J.-J., Goldstein, L., Chen, Y.-J. J., Lee, J., Webster, J. D., Roose-Girma, M., Paudyal, S. C., Modrusan, Z., Dey, A., & Shaw, A. S. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020020220 · Cited by 188
Metadata
- Authors
- Rosenberg, A. Z., & Kopp, J. B.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Rosenberg, Avi Z.
- Kopp, Jeffrey B.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2017-02-27
- Volume
- 12
- Issue
- 3
- Pages
- 502-517
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- PMC
- PMC5338705
- OpenAlex
- W2593771998
- Cited by
- 562
- References
- 145
- Citations by year
- 2026: 43 · 2025: 71 · 2024: 86 · 2023: 79 · 2022: 79 · 2021: 62 · 2020: 65 · 2019: 46 · 2018: 22 · 2017: 9
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johns Hopkins University
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Keywords
- focal segmental glomerulosclerosis, APOL1 risk alleles, renal biopsy, podocyte ultrastructure, genetic testing
- MeSH terms
- Apolipoprotein L1, Angiotensin-Converting Enzyme Inhibitors, Drug Therapy, Combination, Glomerulosclerosis, Focal Segmental, Glucocorticoids, Humans, Immunosuppressive Agents, HIV Infections, Angiotensin Receptor Antagonists, Calcineurin Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.